Covered recipient · General Payments record
ELAINE ROSACI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024–2025
$771.97
- Reported across 34 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $286.66 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $71.69 | 4 |
| Acerta Pharma LLC | $66.89 | 3 |
| Amgen Inc. | $32.61 | 2 |
| Medtronic, Inc. | $20.74 | 1 |
| PFIZER INC. | $20.42 | 1 |
| PhotoniCare Inc | $19.90 | 1 |
| GlaxoSmithKline, LLC. | $18.73 | 1 |
| Paratek Pharmaceuticals, Inc. | $18.20 | 1 |
| Merck Sharp & Dohme Corporation | $17.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.39 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229342949 | CMS |
| Amgen Inc. | $17.22 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229342938 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.09 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206178538 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.96 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207094746 | CMS |
| AstraZeneca Pharmaceuticals LP | $32.84 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206843578 | CMS |
| GlaxoSmithKline, LLC. | $18.73 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190417543 | CMS |
| Medtronic, Inc. | $20.74 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219808639 | CMS |
| Merck Sharp & Dohme LLC | $17.48 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238166224 | CMS |
| Novo Nordisk Inc | $18.13 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188817254 | CMS |
| Novo Nordisk Inc | $22.19 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188469966 | CMS |
| Novo Nordisk Inc | $16.17 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188950163 | CMS |
| Novo Nordisk Inc | $15.20 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188979259 | CMS |
| Paratek Pharmaceuticals, Inc. | $18.20 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181781909 | CMS |
| PFIZER INC. | $20.42 | 01/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229251549 | CMS |
| PhotoniCare Inc | $19.90 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1182991093 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.